Opdivo, Bristol Myers Squibb

FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
 · 2hBecker's Hospital Review
FDA approves injectable version of popular cancer drug
The FDA approved a subcutaneous injection version of Bristol Myers Squibb nivolumab and hyaluronidase-nvhy for the treatment of several cancers including melanoma, non-small cell lung cancer and renal cell carcinoma.
US FDA approves injectable form of Bristol Myers' Opdivo
FDA recalls hair spray brand in 12 states over solvent linked to health risks
Initially the hair spray brand was a voluntarily recalled by CRLAB USA, based in California, on Dec. 12 and became a Class II recall by the FDA on Dec. 26.
Lay's potato chips, cucumbers, puppy food and more FDA recalls in December 2024
Most of the recalls are contamination or allergen-based. While 2025 is near, there are still callbacks to be aware of. Here is a list of December recalls according to the FDA. FDA
Hair Spray Recall in 12 States As FDA Issues Risk Warning
Dichloromethane, a volatile solvent commonly used in industrial applications, has been banned in products in many areas, including the U.S. and the European Union, due to its potential health risks.
McKnight's Long-Term Care News12h
FDA approves first generic liraglutide once-daily injection
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes.
Could the FDA's Approach to Vaping Cause an Increase in Smoking?
In early December, the Supreme Court heard oral argument in Food and Drug Administration v. Wages and White Lion Investments, a challenge to the FDA's
STAT9h
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two new clinical trials.
FDA proposes new tests to detect asbestos in cosmetics and other products containing talc
FDA proposes rule to target asbestos in talc cosmetic products
FDA proposes new testing rules to ensure cosmetics are asbestos-free
FDA announces recall of Systane eye drops due to fungal contamination
The FDA has issued a recall for specific lots of Systane eye drops due to potential fungal contamination after a consumer complaint. Users are advised to stop using the product immediately and return it for a refund or replacement.
Scientific American3d
The FDA Is Changing What Foods Can Be Called ‘Healthy’
Whole grains and fruits are in, and added sugar is out. That’s going to change what’s on a lot of cereal boxes and other things
wjactv3h
FDA issues temporary recall of new Gardners 'Cappuccino Meltaway' candy bars
BLAIR COUNTY, Pa (WJAC) — The U.S. Food and Drug Administration (FDA) has issued a temporary recall of the latest Gardners Candies' specialty candy bars. According to the announcement, the Blair County-based candy company is recalling its new "Cappuccino Meltaway" bars due to an undeclared tree nut allergen and packaging issue.
Systane eye drops recalled due to fungal contamination: FDA
One lot of Systane Lubricant Eye Drops Ultra PF, manufactured by Alcon Laboratories, has been recalled due to fungal contamination, the FDA announced this week.